Clinical Trial Update: The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of gemcitabine and docetaxel in pancreatic and biliary cancers, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Pancreatic Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemzar (gemcitabine)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Pancreatic Neoplasms, Biliary Tract Neoplasms | Phase 2 | Status: COMPLETED